Dr. Christina Vallgren
PhD in Applied Physics (Chalmers University of Technology, Sweden/CERN). MSc in Applied Physics and Nuclear Engineering (Chalmers University of Technology, Sweden). MBA. PMI. Staff Physicist at CERN 12+ years. Before coming to CERN, Christina earned an MSc degree in nuclear physics from Chalmers University of Technology, Sweden and did her master thesis in evaluation and study of control rods performance in various nuclear power plants. The work was carried out at Westinghouse, Sweden and KKL, nuclear power plant in Leibstadt, Switzerland. In 2008 she joined CERN for a PhD in applied physics and has worked there for the last 12 years (Summer Student 2007 -> PhD 2008-2011 -> Senior Research Fellow 2011-2014 -> Staff Physicist 2014-2019). Christina was the main responsible for the LHC (Large Hadron Collider, 27 km, the world’s biggest accelerator) Beam Vacuum (the world’s biggest vacuum system) Operation and has also been the supervisor for five master students and two fellows. She is also a scientific journal referee for IEEE Transactions on Nuclear Science.
Dr. Marcus Palm
PhD in Applied Physics (Vienna University of Technology, Austria/CERN). MSc in Applied Physics and Electrical Engineering (Linköping University, Sweden). Detector Physicist at CERN 13 years: expertise in hadron therapy design, commissioning, CE-certification of medical devices, development of high performance detector systems, various detection technologies and data analysis. Marcus earned an MSc degree in Applied Physics and Electrical Engineering from Linköping University, Sweden. He joined CERN in 2006 and carried out his master thesis in design, implementation and operation of diamond detectors and electron multipliers for a novel kind of neutrino factory. During 2008-2011, he did a PhD at MedAustron/CERN on performance requirement of the entire beam delivery system from the accelerator to the patient, and translated clinical requirements on dose quality into hardware specifications on different elements. Directly after his PhD, Marcus continued at MedAustron as Systems Engineer in the Medical Frontend-group. He was then responsible for the system architecture of different patient safety systems and subsystem integration. Later, he was also working on system validation of the entire facility as a single medical device, for CE-certification. Before the creation of Terapet, he was the main responsible for two light-based detectors in the Large Hadron Collider (LHC) at CERN.
Prof. Raymond Miralbell, M.D. Ph.D.
Medical director at Centro de Protonterapia of Quirónsalud, Madrid, Spain, since 2019. Chairman of Servei de Radiooncologia at Institut Oncològic Teknon of Quironsalud, Barcelona, Spain. Chairman and Associated Professor of the Radiation Oncology Division, at the University Hospitals of Geneva (Switzerland) 2006-2019. Chairman of the Swiss Proton Users Group 2000 - 2008. Radiation oncologist trained from 1979 through 1989 in the University of Barcelona and the University of Harvard. Main research domain: Prostate cancer, breast cancer, proton therapy. - Imaging for radiotherapy treatment planning - Treatment precision optimization through image guided radiotherapy - Tracing of the biochemical relapse after curative surgery or radiotherapy - Prognostic value of hypoxic markers (pathological and imaging) - Quality of life studies in fragile patients on androgen deprivation - Biological modeling of prostate cancer response to irradiation and fractionation sensitivity. - Biological modeling for salvage radiotherapy after post-irradiation local failure - Stereo-tactic beam radiotherapy for prostate, gynecologic, ocular/orbital, and oligometastatic tumors.
Maarten Schokker
Project Manager with in depth knowledge of quality assurance systems for medical devices (ISO 13485), risk analysis (ISO 14971) and software life cycle (IEC 62304). Founder of FilFla (BE). Expertise: Successful design, development, FAT/SAT and CE-certification of an operating ion beam therapy facility. Electronic design and development.
Hervé Duffour
From 1997 in the Medical Imaging industry, first as an Account Manager & Modality Sales Specialist for Marconi (formally Picker) & Philips; then as a Marketing, Sales & Service director for Swiss Medical Care (contrast media injectors) and finally various managing roles at Bracco Injeneering (Radiology Medical Devices) part of the Bracco Imaging pharmaceutical group. During these 7 years at Bracco Injeneering, Hervé started with operational roles such as Sales & Marketing support and the management of the Customer Service global organization. Then he moved up to a strategic role as the Upstream Marketing Director. He was in charge of the definition of the product roadmap, assessing new business opportunities, conducting market researches and managing business intelligence. And finally, he managed the product training worldwide within the organization. Hervé holds an EPFL Master’s degree in Microelectronics and a HEC post-graduate degree in Business Management. This dual technical & business backgrounds allows him to easily interact and understand customer needs and unmet needs and translate them into technical specifications.
Dr. Ben Brunt
PhD in Particle Physics (University of Cambridge, UK), MPhys in Physics (University of Oxford, UK). Before joining Terapet, Ben held a CIO (Chief Information Officer) position at Milkalyser Ltd, a biotech start-up based in Exeter, UK. At Milkalyser, Ben led the lab and field validation of the company's automated hormone analysis system. Milkalyser was acquired by Lely NV in January 2020. Following the acquisition, Ben acted as the technical contact between the Exeter development team and the parent company. In 2018, Ben completed a PhD at the University of Cambridge, focusing on the analysis of data from the ATLAS detector at the Large Hadron Collider (LHC at CERN) in search of exotic physics processes.
Dr. Michael Betz
PhD in Electrical Engineering (Karlsruhe Institute of Technology, Germany / CERN), MSc in Electrical Engineering (Hochschule Karlsruhe, Germany). Before joining Terapet, Michael held a RF Electronics Engineer position at Lawrence Berkeley Labs (LBL) in US for the last five years. At LBL, Michael worked on design, development and troubleshooting of instrumentation and control systems in the ALS (Advanced Light Source) accelerator complex. Prior to that, Michael did his master thesis, his PhD thesis and the postdoctoral fellowship at CERN during 2009-2016.
Luca Terradura
BSc in Mechanical Engineering at HES-SO (University of Applied Sciences Geneva - HEPIA). While working at Terapet, Luca is also pursuing a MSE in Energy and Environment at HES-SO. Prior to joining Terapet, Luca gained professional experience from several projects, such as the design and mechanical integration of a concept hydrogen fueled e-bike.
Anna Walstra
BSc in Technical Medicine at the Leiden University Medical Center, Delft University of Technology & Erasmus University Medical Center Rotterdam. Anna is joining Terapet for a three-month internship as part of her final MSc year in Technical Medicine. In prior internships Anna gained clinical and professional experience at the Nuclear Medicine and Radiotherapy departments, where she tested novel PET-guided biopsy instruments and applied Deep-Learning to assess the radiosensitivity of tumors.
Robin Chappuis
BSc in Industrial Design Engineering, specialized in ergonomics & industrial design at HES-SO (Haute école ARC Neuchatel). Before joining Terapet, Robin worked in the development of several projects in the engineering field, such as the update of automated assembly lines and the development of bicycle frames.
Carla Pou Miralbell
BSc in Bioengineering at International University of Catalonia (UIC). Carla is joining Terapet for five-month internship as part of her final BSc year. Before coming to the team, Carla gained clinical and academical experience at SIMM Medical Imaging and Nuclear Medicine in Barcelona, where she focused on metabolic therapy and PET/SPECT imaging devices. Also, she has worked as laboratory assistant at the Bioengineering Institute of Technology (BIT) developing biomaterials-based hydrogel microspheres.
Board of Directors
Giovanni Leo
Partner at Lake Geneva Ventures
Sebastian Anastasiou
Principal, head of investments at Nina Capital
Advisory board
Prof. Rolf Lewensohn, M.D. Ph.D.
Prof. Rolf Lewensohn, M.D., Ph.D. serves as Senior Consultant at the department of Oncology, Karolinska University Hospital. Prof. Lewensohn is the Founder of Oncopeptides AB. He has a scientific background in DNA repair and apoptotic signaling in cancer, related to cancer therapy. He has published over 110 scientific publications within the cancer field. He serves as a Director of Karolinska Clinical Biomics Centre. He serves as a member of the scientific board of several funding bodies e.g. the Swedish Cancer Society, the Stockholm Cancer Society and King Gustav V’s Jubilee fund.
Håkan Ludvigson
Serial entrepreneur with 15+ years of experience. Currently CEO and founder of Eliq AB (a software company that helps utilities to engage their customers by providing rich energy insights tools to consumers. The company is based between Gothenburg, Sweden and London, UK.). Founder of Acosense (acoustic spectroscopy sensor technology). Expertise: Business development, market strategy
Mikael Arthursson
Serial entrepreneur with 15+ years of experience. Currently CTO and founder of Minalyze AB. Minalyze AB was founded in 2009 in Gothenburg, Sweden and is the world leader in XRF core scanning instruments and software for visualization of geological data. The company is based both in Sweden and Australia today. Expertise: Business development in HighTech, market strategy
About Us
Founder team: Prof. Raymond Miralbell (left), Dr. Christina Vallgren (middle) and Dr. Marcus Palm (right).
Multidisciplinary team:
Network
Technical
Clinical
Regulatory
Business